EP1929999
Notkun á agómelantíni til að fá fram lyf sem miðar að því að meðhöndla Smith-Magenis heilkenni.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.11.2007EP published:
16.3.2011EP application number:
07291391.6
EP translation filed:
26.5.2011Grant published:
15.6.2011EPO information:
European Patent Register
Max expiry date:
22.11.2027Expiry date:
22.11.2019
Title:
Use of agomelatine to obtain medication aimed at treating Smith-Magenis Syndrome
Timeline
Today
23.11.2007EP application
16.3.2011EP Publication
26.5.2011Translation submitted
15.6.2011Registration published
22.11.2019Expires
Owner
Name:
Les Laboratoires ServierAddress:
12, Place de La Défense, 92415, Courbevoie Cedex, FR
Inventor
Name:
Mocaer, ElisabethAddress:
Neuilly sur Seine, FR
Name:
Fabiano, AgnèsAddress:
Verona, IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0610296Date:
24.11.2006Country:
FR
Classification
Categories:
A61K 31/165, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 22.11.2011
Expires: 22.11.2012
Payer: Árnason Faktor
Number: 6
Paid: 22.11.2012
Expires: 22.11.2013
Payer: Árnason Faktor
Number: 7
Paid: 21.11.2013
Expires: 22.11.2014
Payer: Árnason Faktor
Number: 8
Paid: 24.11.2014
Expires: 22.11.2015
Payer: Árnason Faktor
Number: 9
Paid: 25.11.2015
Expires: 22.11.2016
Payer: Árnason Faktor
Number: 10
Paid: 24.11.2016
Expires: 22.11.2017
Payer: Árnason Faktor
Number: 11
Paid: 5.10.2017
Expires: 22.11.2018
Payer: Árnason Faktor
Number: 12
Paid: 5.10.2018
Expires: 22.11.2019
Payer: Árnason Faktor